Position in NVCT
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$2,124,633
+$1,518,408 QoQ
Shares Held
115,532
+47.3% QoQ
Ownership
0.355%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 82 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCT Over Time
Shares Held
Position Value (USD)
Derivatives in NVCT
reported options exposure · as of Jun 30, 2026CallValue
$937,890
CallShares
51,000
PutValue
$288,723
PutShares
15,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names. NVCT ranks #200 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in NVCT
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $937,890 | 51,000 | Call | Defined | 2026-09-02 | |
| 2026-06-30 | $2,124,633 | 115,532 | Shares | Defined | 2026-09-02 | |
| 2026-06-30 | $288,723 | 15,700 | Put | Defined | 2026-09-02 | |
| 2026-03-31 | $606,225 | 78,425 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $581,350 | 77,000 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $109,475 | 14,500 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $525,546 | 87,300 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $169,569 | 22,700 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $109,424 | 11,200 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $101,060 | 10,344 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $420,110 | 43,000 | Call | Defined | 2025-05-15 | |
| 2024-06-30 | $94,551 | 14,937 | Shares | Defined | 2024-08-14 | |
| 2023-06-30 | $447,607 | 28,028 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $392,772 | 35,069 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||